- This event has passed.
Read the Roundtable Takeaways
- Consider health care policies and access barriers around autoimmune diseases, based on the science, to improve patient outcomes
- Identify current health disparities for women, subpopulations of women, and underserved populations with autoimmune diseases and conditions and identify whether current policies and practices exacerbate those disparities
- Review the state of the science and explore the best means to further research and develop more effective outreach, diagnosis, and treatment adherence strategies
- Develop educational materials to raise awareness about autoimmune and immune-mediated diseases among policy decision-makers as well as highlight barriers to access and coverage and offer recommendations on patient-centered health care policies for women with autoimmune diseases.
Nicole Boschi, Director of Regulatory Affairs, National MS Society
Sarah Buchanan, Director of Federal Government Relations & Health Policy, National Psoriasis Foundation
DeAnna Clark, Patient Advocate
Betty Diamond, MD, Director of the Institute of Molecular Medicine, Northwell Health’s Feinstein Institute for Medical Research
Quardricos Driskell, Vice President, Public Policy and Government Affairs, Autoimmune Association
Caren Heller, MD, MBA, Chief Scientific Officer, Crohn’s and Colitis Foundation
Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation
Presha Kardile, Patient Advocate
Sonia Manocha, Rheumatology Division, Allegheny Health Network
Carolyn Serraino, Director of Research, Global Autoimmune Institute
Sonia Sharma, Associate Professor, Center for Autoimmunity and Inflammation, Center for Cancer Immunotherapy, La Jolla Institute for Immunology
Sandy Werness, Executive Director, Global Autoimmune Institute
SWHR’s Autoimmune Program is supported by an educational sponsorship from Horizon Therapeutics. SWHR maintains editorial control and independence over educational content.